Dubai health authority backs new oral medication for MS

Gilenya, or Fingolimod, is the first approved oral disease modifying drug for MS.

Dubai health authority backs new oral medication for MS

Postby MSUK » Wed Mar 23, 2011 3:49 am


The UAE's Multiple Sclerosis (MS) community is set to become the first in the region to benefit from a new oral medication designed to reduce debilitating symptoms and prevent disability, it was announced today by Dr. Ali Al Sayed, Director of Pharmaceutical Services, Dubai Health Authority (DHA).

Dr. Al Sayed said the new therapy called Gilenya (fingolimod) is now available in the UAE after being approved as a first-line treatment in a number of countries for relapsing forms of MS, which affect two-thirds of those diagnosed with the disease that causes muscle weakness, problems with coordination, and impaired concentration. Up until now MS patients have had to inject their medications.... Read More - ... ageid/1309
User avatar
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 3:00 pm


Return to Gilenya


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service